CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma

被引：64
|
作者：
Madduri, Deepu
Berdeja, Jesus G.
Usmani, Saad Z.
Jakubowiak, Andrzej
Agha, Mounzer
Cohen, Adam D.
Stewart, A. Keith
Hari, Parameswaran
Htut, Myo
O'Donnell, Elizabeth
Munshi, Nikhil C.
Avigan, David E.
Deol, Abhinav
Lesokhin, Alexander M.
Singh, Indrajeet
Zudaire, Enrique
Yeh, Tzu-Min
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Deraedt, William
Zhuang, Sen Hong
Infante, Jeffrey R.
Geng, Dong
Wu, Xiaoling
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Rizvi, Syed
Fan, Frank
Jagannath, Sundar
Lin, Yi
Martin, Thomas, III
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136307
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta-analysis
    Gagelmann, Nico
    Ayuk, Francis
    Atanackovic, Djordje
    Kroeger, Nicolaus
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (04) : 318 - 327
  • [42] B-cell maturation antigen chimeric antigen receptor-T therapy alleviated heart failure in patients with multiple myeloma
    Wang, Yunhong
    Zhang, Ke
    Suo, Xiaohui
    Meng, Ning
    Gu, Yuanrui
    Qin, Yilang
    Tu, Yanxia
    Zhang, Xiaohui
    Sun, Guofeng
    Ji, Jiaojiao
    Wu, Weichun
    Cai, Yuqi
    Yang, Kai
    Ouyang, Chenxi
    Qi, Junyuan
    ESC HEART FAILURE, 2024, 11 (01): : 574 - 580
  • [43] Safety and efficacy of B cell maturation antigen-directed CAR T-cell therapy in patients with relapsed/refractory multiple myeloma and concurrent light chain amyloidosis
    Goel, Utkarsh
    Dima, Danai
    Davis, James
    Ahmed, Nausheen
    Shaikh, Hira
    Lochner, Jonathan
    Abdallah, Al-Ola
    Khouri, Jack
    Hashmi, Hamza
    Anwer, Faiz
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (06) : 817 - 823
  • [44] A Novel Composite Endpoint of Toxicity- and Progression-Free Survival after B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Mohty, Razan
    Junmin, Whiting
    Saha, Aditi
    Kim, Jongphil
    Nishihori, Taiga
    De Avila, Gabriel
    Corallo, Salvatore
    Dam, Marian
    Marin, Jessica
    Liu, Hien
    Mokhtari, Sepideh
    Jain, Michael D.
    Perna, Fabiana
    Blue, Brandon
    Grajales-Cruz, Ariel F.
    Castaneda, Omar
    Shain, Kenneth
    Baz, Rachid
    Freeman, Ciara Louise L.
    Alsina, Melissa
    Locke, Frederick L.
    Hansen, Doris K.
    Lazaryan, Aleksandr
    BLOOD, 2023, 142
  • [45] A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma
    Chen, Dongjian
    Zhu, Yu
    Chen, Zhi
    Jiang, Songfu
    He, Haiyan
    Qiang, Wanting
    Xiang, Fang
    Sun, Xuedong
    Du, Juan
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3747 - 3756
  • [46] Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
    Ma, Tiantian
    Shi, Jing
    Liu, Huasheng
    ANNALS OF HEMATOLOGY, 2019, 98 (04) : 813 - 822
  • [47] Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
    Tiantian Ma
    Jing Shi
    Huasheng Liu
    Annals of Hematology, 2019, 98 : 813 - 822
  • [48] Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011).
    Mailankody, Sham
    Jakubowiak, Andrzej J.
    Htut, Myo
    Costa, Luciano J.
    Lee, Kelvin
    Ganguly, Siddhartha
    Kaufman, Jonathan L.
    Siegel, David Samuel DiCapua
    Bensinger, William
    Cota, Mariana
    Doerr, Thomas
    DeVries, Todd
    Wong, Sandy Wai Kuan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Preclinical development of a humanized chimeric antigen receptor against B-cell maturation antigen for multiple myeloma
    Perez-Amill, Lorena
    Sune, Guillermo
    Antonana-Vildosola, Asier
    Castella, Maria
    Najjar, Amer
    Bonet, Jaume
    Fernandez-Fuentes, Narcis
    Inoges, Susana
    Lopez, Ascension
    Bueno, Clara
    Juan, Manel
    Urbano-Ispizua, Alvaro
    Martin-Antonio, Beatriz
    HAEMATOLOGICA, 2021, 106 (01) : 173 - 184
  • [50] Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma
    Zhang, Qiqi
    Zu, Cheng
    Jing, Ruirui
    Feng, Youqin
    Zhang, Yanlei
    Zhang, Mingming
    Lv, Yuqi
    Cui, Jiazhen
    Zhou, Linhui
    Meng, Ye
    Wang, Linqin
    Cen, Zenan
    Chang, Alex H. H.
    Hu, Yongxian
    Huang, He
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345